Efficacy of Risperidone for Behavioral Disorders in the Elderly: A Clinical Observation

Abstract

Standard antipsychotics are ineffective in some geriatric patients. In addition, they are not helpful for apathy and withdrawal. Studies have demonstrated that 5HT₂ antagonists improve affective symptoms and anxiety; therefore, the efficacy of risperidone on agitation and withdrawal was considered. The literature on risperidone was reviewed, and the efficacy and limitations of risperidone observed in two geriatric patients, one with agitation and another with apathy and withdrawal. Risperidone proved to be effective in controlling disruptive behavior in geriatric patients. Combined antagonism of D₂ and 5HT₂ receptors might be effective in improving agitation and withdrawal. Risperidone, with both D₂ and 5HT₂ antagonistic properties, seems to have potential as an alternative agent in controlling agitation and withdrawal in geriatric patients. Caution and need for further observation is recommended.

Get full access to this article

View all access options for this article.

References

1. McGuire MT , Troisi A. Aggression. Comprehensive textbook of psychiatry. V. Baltimore: Williams and Wilkins, 1989: 279.

2. Guttamacher LB . Concise guide to psychopharmacology and electroconvulsive therapy. Washington, DC: American Psychiatric Press Inc, 1994: 21–31.

3. Lawlor BA . Serotonin and Alzheimer's disease. Psychiatr Ann 1990; 20:567–570.

4. Meltzer HY . The role of serotonin in the action of atypical antipsychotic drugs. Psychiatr Ann 1990; 20:571–579.

5. Hillert A , Mair W , Wetzal H , Benkert O. Risperidone in treatment of disorders with combined psychotic and depressive syndrome—a functional approach. Pharmacopsychiatry 1992; 25:213–217.

6. Vanden Borre R , Vermote R , Buttiens M , Thiry P. Risperidone as an add-on therapy in behavioral disturbances in mental retardation: a double blind placebo controlled study. Acta Psychiatr Scand 1993; 87:167–171.

7. Frankenburg FR , Kalunian D. Clozapine in the elderly. J Geriatr Psychiatry Neurol 1994; 7:131–134.

8. Land W , Salzman C. Risperidone: a novel antipsychotic medication. Hosp Community Psychiatry 1994; 45:434–435.

9. Ford B. Risperidone in Parkinson's disease. Lancet 1994; 344:681. Letter.

10.

10. Kane, JM . Newer antipsychotic drugs. A review of their pharmacology and therapeutic potential. Drugs 1993; 46:585–593.